---
title: "Hicin Pharmaceutical (300584.SZ) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300584.SZ/norm.md"
symbol: "300584.SZ"
name: "Hicin Pharmaceutical"
parent: "https://longbridge.com/en/quote/300584.SZ.md"
datetime: "2026-03-05T00:43:51.592Z"
locales:
  - [en](https://longbridge.com/en/quote/300584.SZ/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300584.SZ/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300584.SZ/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/300584.SZ/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/300584.SZ/norm.md)


# Hicin Pharmaceutical (300584.SZ) — Financial Reports

## Income Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.0293 | 0.1177 | 0.1253 | 0.1008 | 0.0282 |
| ROE | 1.35% | 5.44% | 5.84% | 4.76% | 1.34% |
| Revenue | 162.95M | 165.92M | 142.65M | 143.86M | 123.97M |
| Net income | 3.52M | 14.12M | 15.04M | 12.10M | 3.38M |
| Operating income | 17.98M | 13.49M | 22.21M | 7.21M | 12.22M |
| Gross margin | 84.38% | 80.07% | 86.09% | 77.65% | 84.67% |
| Net margin | 2.16% | 8.51% | 10.54% | 8.41% | 2.73% |
| Profit quality | -251.42% | 60.03% | 51.46% | 45.00% | 167.12% |

## Balance Sheet (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.48B | 1.48B | 1.48B | 1.46B | 1.42B |
| Leverage | 1.38 | 1.41 | 1.40 | 1.41 | 1.41 |
| BVPS | 8.69 | 8.67 | 8.65 | 8.52 | 8.42 |
| Turnover | 0.4235 | 0.3964 | 0.3752 | 0.3511 | 0.3620 |
| Cash & STI | 76.14M | 71.23M | 51.24M | 45.76M | 38.20M |
| Inv & Rec | 76.20M | 77.72M | 86.60M | 85.67M | 86.71M |
| LT assets | 811.36M | 797.21M | 801.58M | 763.73M | 715.82M |
| Net debt | 221.19M | 239.21M | 264.61M | 268.98M | 252.30M |

## Cash Flow Statement (CNY)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -7.15M | 22.48M | 43.16M | 16.01M | 7.31M |
| Investing CF | 12.04M | 17.07M | -35.25M | -18.37M | -15.98M |
| Financing CF | 20622.00 | -19.57M | -2.44M | 9.92M | 4.26M |
| Free CF | -28.19M | 34.69M | 10.43M | 15.10M | -32.09M |
| OCF coverage | -17.55% | 21.17% | 48.40% | 9.15% | 8.32% |
| Repaid & issued | 35.40M | 68.60M | 65.50M | 141.60M | 83.90M |
| CapEx | -17.85M | -12.11M | -27.15M | -18.37M | -15.99M |

## Distribution Plan

**Dividend Yield**: 0.24

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.1CNY | 2025-06-06 | 2025-06-09 | 2025-06-09 |
| Cash Dividend: 
0.05CNY | 2024-06-17 | 2024-06-18 | 2024-06-18 |
| Cash Dividend: 
0.25CNY | 2022-05-24 | 2022-05-25 | 2022-05-25 |